Patent Assignment
Reel/Frame 019550/0483
Release of Security Interest
Recorded: 2007-07-13
Pages: 3
Assignor
LEVY, JAY
Executed: 2007-06-29
Assignee
UNIGENE LABORATORIES, INC.
110 LITTLE FALLS ROAD, FAIRFIELD, NEW JERSEY, 07004
Covered Properties
(11)
Alpha-Amidating Enzyme Compositions and Processes for Their Production and Use
Patent:
6,319,685 →
Application:
07/086,161 →
Expression Systems for Amidating Enzyme
Patent:
5,789,234 →
Application:
07/307,366 →
Oral Salmon Calcitonin Pharmaceutical Products
Patent:
5,912,014 →
Application:
08/616,250 →
Direct Expression of Peptides into Culture Media
Patent:
6,103,495 →
Application:
09/060,765 →
Oral Peptide Pharmaceutical Products
Patent:
6,086,918 →
Application:
09/125,500 →
Direct expression of peptides into culture media
Patent:
6,210,925 →
Application:
09/500,009 →
Nasal Calcitonin Formulations
Patent:
6,440,392 →
Application:
09/776,537 →
Direct Expression of Peptides into Culture Media
Process for preparation of sulfonylurea salts
Oral Delivery of Peptides Using Enzyme-Cleavable Membrane Translocators
Oral Peptide Pharmaceutical Dosage Form and Method of Production
Related Assignments
(16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Security Interest
Sep 28, 2007
From: LEVY, JAY
To: JAYNJEAN LEVY FAMILY LIMITED PARTNERSHIP
Reel/Frame 019892/0459 →
Amended and Restated Patent Security Agreement
Oct 11, 2007
From: UNIGENE LABORATORIES, INC.
To: JAYNJEAN LEVY FAMILY LIMITED PARTNERSHIP
Reel/Frame 019943/0714 →
Release of Security Interest
Oct 1, 2008
From: OLYMPUS SECURITIES, LTD.; NELSON PARTNERS, CITADEL INVESTMENT MANAGEMENT, L.P., CITADEL INVESTMENT MANAGEMENT, INC.
To: UNIGENE LABORATORIES, INC.
Reel/Frame 021603/0790 →
Security Agreement
Oct 3, 2008
From: UNIGENE LABORATORIES, INC.
To: VICTORY PARK MANAGEMENT, LLC
Reel/Frame 021630/0352 →
Assignment of Assignor's Interest
Apr 26, 2013
From: UNIGENE LABORATORIES, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 030300/0538 →
Assignment of Assignor's Interest
Jul 23, 2013
From: UNIGENE LABORATORIES, INC.
To: UGP THERAPEUTICS, INC.
Reel/Frame 030856/0340 →
Assignment of Assignor's Interest
Sep 11, 2013
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 031185/0455 →
Assignment of Assignor's Interest
Mar 13, 2014
From: MEHTA, NOZER M.; CONSALVO, ANGELO P.; RAY, MARTHA V.L.; MEENAN, CHRISTOPHER P.
To: UNIGENE LABORATORIES, INC.
Reel/Frame 032434/0418 →
Assignment of Assignor's Interest
Mar 13, 2014
From: UNIGENE LABORATORIES, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 032434/0431 →
Assignment of Assignor's Interest
Mar 17, 2014
From: MEHTA, NOZER M.; CONSALVO, ANGELO P.; RAY, MARTHA V.L.; MEENAN, CHRISTOPHER P.
To: UNIGENE LABORATORIES, INC.
Reel/Frame 032457/0801 →
Assignment of Assignor's Interest
Jul 18, 2016
From: UNIGENE LABORATORIES, INC.
To: UGP THERAPEUTICS, INC.
Reel/Frame 039182/0406 →
Assignment of Assignor's Interest
Jul 19, 2016
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 039184/0797 →
Corrective Assignment to Correct the Nature of Conveyance Previously Recorded on Reel 039184 Frame 0797. Assignor(S) Hereby Confirms the Nunc Pro Tunc Assignment Effective 02/01/2016.
Aug 15, 2016
From: UGP THERAPEUTICS, INC.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 039682/0212 →
Release of Security Interest
Aug 8, 2019
From: VICTORY PARK MANAGEMENT, LLC
To: UNIGENE LABORATORIES, INC.
Reel/Frame 050000/0762 →
Security Interest
Aug 26, 2019
From: ENTERIS BIOPHARMA, INC.
To: CADENCE BANK, N.A.
Reel/Frame 050174/0428 →
Release of Security Interest
Jun 28, 2023
From: CADENCE BANK, A MISSISSIPPI BANK AND SUCCESSOR BY MERGER TO CADENCE BANK, N.A., A NATIONAL BANKING ASSOCIATION, AS AGENT
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 064149/0741 →